We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$17.4B
AUM Growth
+$545M
Cap. Flow
-$192M
Cap. Flow %
-1.1%
Top 10 Hldgs %
9.28%
Holding
1,212
New
62
Increased
223
Reduced
366
Closed
61

Sector Composition

Rank Sector Weight
1 Industrials 17.33%
2 Communication Services 13.84%
3 Financials 10.01%
4 Utilities 9.83%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVC icon
1026
Entravision Communication
EVC
$983M
$274K ﹤0.01%
56,000
FTV icon
1027
Fortive
FTV
$19B
$271K ﹤0.01%
5,101
PPC icon
1028
Pilgrim's Pride
PPC
$6.82B
$271K ﹤0.01%
15,000
TTPH
1029
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$265K ﹤0.01%
4,800
-1,300
-21% -$83K
WIN
1030
DELISTED
Windstream Holdings Inc
WIN
$259K ﹤0.01%
52,900
-176,026
-77% -$795K
IIIV icon
1031
i3 Verticals
IIIV
$395M
$253K ﹤0.01%
+11,000
New +$196K
UTI icon
1032
Universal Technical Institute
UTI
$2.08B
$253K ﹤0.01%
95,000
-15,000
-14% -$43.9K
SCX
1033
DELISTED
The L.S. Starrett Company
SCX
$252K ﹤0.01%
42,000
HR icon
1034
PUT
Healthcare Realty
HR
$7.42B
$250K ﹤0.01%
100
CHA
1035
DELISTED
China Telecom Corporation, LTD
CHA
$247K ﹤0.01%
5,000
NYT icon
1036
New York Times
NYT
$11.6B
$232K ﹤0.01%
10,000
CBPO
1037
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$232K ﹤0.01%
+2,900
New +$270K
VALE icon
1038
Vale
VALE
$62.9B
$223K ﹤0.01%
15,000
TRU icon
1039
TransUnion
TRU
$14.8B
$221K ﹤0.01%
3,000
VNE
1040
DELISTED
Veoneer, Inc.
VNE
$220K ﹤0.01%
+4,000
New +$206K
RARX
1041
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$218K ﹤0.01%
12,037
ENIA
1042
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$216K ﹤0.01%
28,000
IESC icon
1043
IES Holdings
IESC
$12.5B
$215K ﹤0.01%
11,000
LXRX icon
1044
Lexicon Pharmaceuticals
LXRX
$1.02B
$213K ﹤0.01%
20,000
+1,000
+5% +$11.5K
NKTR icon
1045
Nektar Therapeutics
NKTR
$2.39B
$213K ﹤0.01%
+233
New +$199K
HST icon
1046
Host Hotels & Resorts
HST
$16.8B
$211K ﹤0.01%
10,000
-4,422
-31% -$93.5K
CPB icon
1047
PUT
Campbell Soup
CPB
$6.51B
$210K ﹤0.01%
100
CLVS
1048
DELISTED
Clovis Oncology, Inc.
CLVS
$203K ﹤0.01%
6,900
+1,500
+28% +$58.1K
OUT icon
1049
Outfront Media
OUT
$5.64B
$200K ﹤0.01%
+10,160
New +$202K
ZNGA
1050
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$198K ﹤0.01%
49,396
-17,600
-26% -$70.8K

Similar funds

Gabelli Funds's Q3 2018 Portfolio in Review

As of Q3 2018, Gabelli Funds held 1,212 positions worth $17.4B, up 3.2% from $16.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Gabelli Funds's Q3 2018 filing shows 62 new, 223 increased, 366 reduced and 61 closed positions. Its largest new stake was CA, Inc.: 1,669,874 shares worth $73.7M. The largest sale was XL Group Ltd., an estimated $59.5M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 17% a quarter earlier, followed by Communication Services and Financials.

  • Gabelli Funds's largest Q3 2018 buy was CA, Inc.: 1,669,874 shares worth $73.7M.
  • Gabelli Funds added most to Dun & Bradstreet in Q3 2018, an estimated $39.8M increase.
  • Gabelli Funds's biggest Q3 2018 reduction was Evergy, cutting an estimated $30.8M.
  • Gabelli Funds fully exited XL Group Ltd. in Q3 2018, selling an estimated $59.5M.
  • Gabelli Funds's ten largest holdings make up 9.3% of its $17.4B portfolio in Q3 2018.
  • Gabelli Funds opened 62 new positions and closed 61 in Q3 2018.
  • Gabelli Funds's portfolio value rose 3.2% quarter-over-quarter to $17.4B.

Based on Gabelli Funds's 13F filing for Q3 2018, filed 2 Nov 2018.